MEDIROM Healthcare Technologies SG&A Expenses 2021-2023 | MRM
MEDIROM Healthcare Technologies sg&a expenses from 2021 to 2023. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| MEDIROM Healthcare Technologies Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2022 | $14 |
| 2021 | $17 |
| 2020 | $10 |
| 2019 | $ |
| MEDIROM Healthcare Technologies Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.028B | $0.053B |
| MEDIROM Healthcare Technologies Inc. is a holistic healthcare company. MEDIROM Healthcare Technologies Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.045B | 10.31 |
| Quest Diagnostics (DGX) | United States | $15.348B | 15.86 |
| DaVita (DVA) | United States | $12.097B | 15.03 |
| Encompass Health (EHC) | United States | $8.696B | 22.26 |
| Chemed (CHE) | United States | $8.692B | 26.94 |
| Elanco Animal Health (ELAN) | United States | $8.500B | 22.05 |
| Option Care Health (OPCH) | United States | $5.263B | 19.92 |
| RadNet (RDNT) | United States | $3.959B | 82.42 |
| Amedisys (AMED) | United States | $3.090B | 21.89 |
| LifeStance Health (LFST) | United States | $2.722B | 0.00 |
| Astrana Health (ASTH) | United States | $2.188B | 29.58 |
| Addus HomeCare (ADUS) | United States | $1.737B | 24.85 |
| U.S Physical Therapy (USPH) | United States | $1.583B | 42.35 |
| Pennant (PNTG) | United States | $0.668B | 35.30 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.477B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.343B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.021B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.012B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.011B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |